News
ANIX
2.850
-2.06%
-0.060
Weekly Report: what happened at ANIX last week (0506-0510)?
Weekly Report · 6d ago
Anixa Biosciences enters JV with Cleveland Clinic for additional cancer vaccines
Anixa Biosciences enters JV with Cleveland Clinic for additional cancer vaccines for various cancer types. The vaccines were developed at Cleveland Clinic and licensed to Anixa. Cleveland Clinic is entitled to royalties and other commercialization revenues from the company. Anix a Bioscience, Inc. (ANIX)
Seeking Alpha · 05/08 12:55
Anixa Biosciences Forms Cancer Vaccine Partnership with Cleveland Clinic
TipRanks · 05/08 12:52
Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines
NASDAQ · 05/08 12:46
ANIXA BIOSCIENCES INC - CLEVELAND CLINIC IS ENTITLED TO ROYALTIES AND OTHER COMMERCIALIZATION REVENUES FROM COMPANY
Reuters · 05/08 12:25
Weekly Report: what happened at ANIX last week (0429-0503)?
Weekly Report · 05/06 10:17
Anixa Biosciences 13D Filing Shows President, COO & CFO Michael Catelani Reported A 5.25% Stake In The Co As Of April 30, 2024
Benzinga · 05/03 17:34
Weekly Report: what happened at ANIX last week (0422-0426)?
Weekly Report · 04/29 10:20
Weekly Report: what happened at ANIX last week (0415-0419)?
Weekly Report · 04/22 10:15
ANIXA BIOSCIENCES WELCOMES CELEBRITY ONCOLOGIST DR. SANJAY JUNEJA TO ITS CANCER BUSINESS ADVISORY BOARD
Reuters · 04/18 12:20
Press Release: Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Dr. Juneja is a board-certified hematologist and medical oncologist.
Dow Jones · 04/18 12:20
Weekly Report: what happened at ANIX last week (0408-0412)?
Weekly Report · 04/15 10:10
Weekly Report: what happened at ANIX last week (0401-0405)?
Weekly Report · 04/08 10:13
Weekly Report: what happened at ANIX last week (0325-0329)?
Weekly Report · 04/01 10:12
Weekly Report: what happened at ANIX last week (0318-0322)?
Weekly Report · 03/25 10:14
Anixa Biosciences Stockholders Affirm Confidence and Oversight
TipRanks · 03/22 20:42
Anixa Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones · 03/21 10:43
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Benzinga · 03/21 10:33
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
TipRanks · 03/21 10:17
Weekly Report: what happened at ANIX last week (0311-0315)?
Weekly Report · 03/18 10:13
More
Webull provides a variety of real-time ANIX stock news. You can receive the latest news about Anixa Biosciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About ANIX
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.